Classification
Product TypeIngredient
Product FormPowder (bulk ingredient) and finished-dose forms (capsules/tablets)
Industry PositionDietary Supplement Ingredient / Micronutrient (Vitamin)
Market
Vitamin B3 (niacin) in the United States is a regulated dietary ingredient used in dietary supplements and also as a nutrient in standardized food enrichment (e.g., enriched flour). Finished supplements must present niacin in a boxed “Supplement Facts” panel following U.S. dietary supplement nutrition labeling rules. U.S. manufacturers are expected to follow dietary supplement cGMP requirements (21 CFR Part 111) for identity, quality control, and records. Imported dietary ingredients and supplements are subject to FDA’s import process, including Prior Notice requirements, and may be detained when violations are identified.
Market RoleDomestic consumption market with both domestic manufacturing and imports
Domestic RoleKey micronutrient ingredient for dietary supplements and food enrichment/fortification in the U.S. market
SeasonalityNon-seasonal industrial production and year-round market availability for ingredient supply and finished supplements.
Specification
Primary VarietyNicotinamide (niacinamide)
Compositional Metrics- Declared on U.S. dietary supplement labels within a “Supplement Facts” panel; niacin appears in the required vitamin/mineral listing order under 21 CFR 101.36.
- Dietary reference values and tolerable upper intake levels for niacin are commonly expressed in mg of niacin equivalents (NE) in U.S. nutrition guidance.
Grades- Compendial/official compendium conformance claims (e.g., “USP”) may be referenced on U.S. dietary supplement labels when applicable under 21 CFR 101.36 (e.g., identifying source ingredients and official compendia).
Supply Chain
Value Chain- Bulk niacin/niacinamide ingredient manufacturing (domestic or imported) → U.S. importer/distributor → blending/premix or contract manufacturing under 21 CFR Part 111 → finished supplement labeling (“Supplement Facts”) → retail/e-commerce distribution
Temperature- No cold chain is typically required; emphasis is on dry, clean, controlled storage to protect ingredient quality and prevent contamination.
Shelf Life- Shelf life and label-claim integrity depend on moisture control, packaging integrity, and cGMP controls for components and finished batches.
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighU.S. FDA enforcement can disrupt supply if vitamin B3 ingredients or niacin-containing supplements appear adulterated or misbranded; products may be detained/refused at the border, and Import Alerts can trigger detention without physical examination (DWPE) for future shipments.Implement rigorous supplier qualification and incoming identity testing, maintain 21 CFR Part 111-compliant records, and validate labeling against 21 CFR 101.36 before shipment and sale.
Consumer Safety MediumHigh supplemental intakes of niacin can cause adverse effects (e.g., flushing with nicotinic acid and, at very high intakes, other harms); product positioning, dose, and label warnings can become a commercial and liability risk in the U.S. market.Align dose and claims with responsible use, ensure accurate Supplement Facts declarations, and apply strong post-market complaint handling and adverse event monitoring.
Documentation Gap MediumImport delays can occur if FDA Prior Notice data are incomplete/incorrect or if import documentation cannot support identity and compliance expectations during screening or follow-up questions.Standardize importer checklists for Prior Notice data elements and keep readily retrievable lot-level documentation (specifications, testing/COAs, and manufacturing records) for rapid FDA response.
Labor & Social- No widely documented product-specific forced-labor controversy is commonly associated with vitamin B3 itself in the U.S. market context; the dominant social risk is consumer harm and loss of trust stemming from adulterated/misbranded supplements and weak quality controls.
FAQ
What forms of vitamin B3 are commonly referenced for U.S. supplements and guidance?U.S. nutrition guidance commonly describes niacin (vitamin B3) as including nicotinic acid and nicotinamide (niacinamide), and these are the two most common forms used in supplements.
What labeling format is required to declare niacin on U.S. dietary supplements?Dietary supplements sold in the U.S. must use a boxed “Supplement Facts” panel and follow the nutrient declaration rules in 21 CFR 101.36, which includes niacin in the required vitamin/mineral listing order.
If importing vitamin B3 as a dietary ingredient into the U.S., is there an FDA pre-arrival requirement?Yes. FDA requires Prior Notice for imported foods covered by the regulation, and FDA guidance explicitly includes dietary supplements and dietary ingredients among the categories that require Prior Notice unless an exemption applies.
When would an NDI notification matter for a vitamin-related supplement in the U.S.?An NDI notification is required when a dietary supplement contains a “new dietary ingredient” and notification is required under the FD&C Act; FDA explains that a “new dietary ingredient” is generally one not marketed in the U.S. in a dietary supplement before October 15, 1994, and the firm is responsible for determining and documenting this status.